Silence Therapeutics PLC Holding(s) in Company (5940J)

TIDMSLN

RNS Number : 5940J

Silence Therapeutics PLC

29 June 2017

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------- 
 
 
 
 1. Identity of the issuer or                                                    Silence Therapeutics Plc 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
-----------------------------------------------------------  -------------------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
--------------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
----------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
----------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
----------------------------------------------------------------------------------------------------- 
 An event changing the breakdown of voting rights 
----------------------------------------------------------------------------------------------------- 
 Other (please                                               Disclosure due to increased aggregation    X 
  specify):                                                  of holdings (See 'Box 13 - Additional 
                                                             Information' below) 
----------------------------------------------------------  ----------------------------------------- 
 3. Full name of person(s)                                               Richard Griffiths and controlled 
  subject to the                                                                             undertakings 
  notification obligation: 
  (iii) 
-----------------------------------------------------------  -------------------------------------------- 
 4. Full name of shareholder(s) 
  (if different from 3.):(iv) 
-----------------------------------------------------------  -------------------------------------------- 
 5. Date of the transaction                                                                  26 June 2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-----------------------------------------------------------  -------------------------------------------- 
 6. Date on which issuer                                                                     29 June 2016 
  notified: 
-----------------------------------------------------------  -------------------------------------------- 
 7. Threshold(s) that is/are 
  crossed or 
  reached: (vi, vii)                                                                            22,23,24% 
-----------------------------------------------------------  -------------------------------------------- 
 
 
 
 8. Notified details: 
---------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
---------------------------------------------------------------------------------------------------------------------- 
 Class/type      Situation previous                Resulting situation after the 
  of              to the triggering                 triggering transaction 
  shares          transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
--------------  --------------------------------  -------------------------------------------------------------------- 
                 Number           Number           Number         Number of                   % of voting 
                  of               of               of shares      voting                      rights (x) 
                  Shares           Voting                          rights 
                                   Rights 
--------------  ---------------  ---------------  -------------  --------------------------  ------------------------- 
                                                   Direct         Direct         Indirect     Direct        Indirect 
                                                                   (xi)           (xii) 
--------------      -----------    -----------    -------------  -------------  -----------  ------------  ----------- 
 
 
  GB00B9GTXM62   15,269,014       15,269,014       17,458,481     17,458,481                  24.94% 
                ---------------  ---------------  -------------  -------------  -----------  ------------  ----------- 
 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of financial   Expiration     Exercise/                       Number of voting              % of voting 
  instrument          date           Conversion                      rights that                   rights 
                      (xiii)         Period (xiv)                    may be 
                                                                     acquired if 
                                                                     the 
                                                                     instrument 
                                                                     is 
                                                                     exercised/ 
                                                                     converted. 
------------------  -------------  ------------------------------  ----------------------------  --------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of           Exercise       Expiration     Exercise/        Number of voting              % of voting 
 financial          price         date           Conversion        rights instrument             rights (xix, 
 instrument                       (xvii)         period            refers to                     xx) 
                                                 (xviii) 
----------------  -------------  -------------  ---------------  ----------------------------  ----------------------- 
                                                                                                Nominal       Delta 
----------------  -------------  -------------  ---------------  ----------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                             Percentage of voting rights 
--------------------------------------------------  ------------------------------------------------------------------ 
 17,458,481                                          24.94% 
--------------------------------------------------  ------------------------------------------------------------------ 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
------------------------------------------------------------------------------------------------ 
   Blake Holdings Limited     7,428,699 
    Seren Investment 
     Management Limited        6,963,708 
    Sarossa Plc                2,189,467 
    Oak Trust Limited            182,837 
    Richard Griffiths 
     direct holdings               1,617 
    Richard Griffiths 
     indirect holdings           692,153 
    Total                     17,458,481 
                             ----------- 
 
 
   The above undertakings are all controlled by Richard 
   Griffiths 
 
 Proxy Voting: 
------------------------------------------------------------------------------------------------ 
 10. Name of the proxy holder: 
-------------------------------------------------------------  --------------------------------- 
 11. Number of voting rights proxy 
  holder will cease to hold: 
-------------------------------------------------------------  --------------------------------- 
 12. Date on which proxy holder will 
  cease to hold voting rights: 
-------------------------------------------------------------  --------------------------------- 
 
 
  13. Additional information:                                   Sarossa Plc has now become 
                                                                a controlled undertaking 
                                                                of Richard Griffiths for 
                                                                DTR rule purposes. As such 
                                                                Sarossa Plc's shareholding 
                                                                in Silence Therapeutics Plc, 
                                                                as shown in box 9, is now 
                                                                aggregated into 'Richard 
                                                                Griffiths and controlled 
                                                                undertakings' disclosures. 
                                                                The movement in shares in 
                                                                this disclosure is due to 

                                                                that aggregation and no further 
                                                                shares in Silence Therapeutics 
                                                                Plc were acquired by Richard 
                                                                Griffiths, his controlled 
                                                                undertakings or Sarossa Plc 
                                                                as part of this disclosure. 
-------------------------------------------------------------  --------------------------------- 
 14. Contact name:                                                               James Sutcliffe 
-------------------------------------------------------------  --------------------------------- 
 15. Contact telephone number:                                                 + 44 1534 719 761 
-------------------------------------------------------------  --------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUKSRRBVANUAR

(END) Dow Jones Newswires

June 29, 2017 06:47 ET (10:47 GMT)